Inside the Diagnostics Industry: Genotyping to Guide Antiplatelet Selection Feasible, Effective
...
...
...
From - Diagnostic Testing & Emerging Technologies
The vast majority of sudden infant death syndrome (SIDS) cases are not the result of genetic heart diseases (GHDs) or a single genetic cause…
From - Diagnostic Testing & Emerging Technologies
New Recommendations Simplify Testing for Chronic Kidney Disease
In late February, The National Kidney Foundation, the American Society for Clinical Pathology, and leading laboratories and…
From - Diagnostic Testing & Emerging Technologies
There is not enough evidence, currently, to support the routine adoption of liquid biopsy tests for any of its promising clinical uses, according to a joint review published…